Treatment of experimental autoimmune uveoretinitis with peroxisome proliferator-activated receptor α agonist fenofibrate

PURPOSE: The peroxisome proliferator-activated receptor α (PPARα) agonist has been approved for treating hypercholesterolemia and lipid abnormalities. Researchers have recently discovered that an anti-inflammatory effect of PPAR agonist may have the potential to treat autoimmune disease. This study...

Descripción completa

Detalles Bibliográficos
Autores principales: Osada, Miho, Sakai, Tsutomu, Kuroyanagi, Kana, Kohno, Hideo, Tsuneoka, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Molecular Vision 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4225135/
https://www.ncbi.nlm.nih.gov/pubmed/25489225

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4225135/
https://www.ncbi.nlm.nih.gov/pubmed/25489225

Ejemplares similares